Cargando…
Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415707/ https://www.ncbi.nlm.nih.gov/pubmed/37576273 http://dx.doi.org/10.1016/j.heliyon.2023.e18809 |
_version_ | 1785087605011906560 |
---|---|
author | Zhang, Xiao Yang, Zijiang Jiang, Jizong Tang, Ming Guan, Longfei Lee, Hangil Wang, Hongyun Xu, Jiahong |
author_facet | Zhang, Xiao Yang, Zijiang Jiang, Jizong Tang, Ming Guan, Longfei Lee, Hangil Wang, Hongyun Xu, Jiahong |
author_sort | Zhang, Xiao |
collection | PubMed |
description | Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002–2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD. |
format | Online Article Text |
id | pubmed-10415707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104157072023-08-12 Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 Zhang, Xiao Yang, Zijiang Jiang, Jizong Tang, Ming Guan, Longfei Lee, Hangil Wang, Hongyun Xu, Jiahong Heliyon Research Article Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002–2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD. Elsevier 2023-07-29 /pmc/articles/PMC10415707/ /pubmed/37576273 http://dx.doi.org/10.1016/j.heliyon.2023.e18809 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Zhang, Xiao Yang, Zijiang Jiang, Jizong Tang, Ming Guan, Longfei Lee, Hangil Wang, Hongyun Xu, Jiahong Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title | Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title_full | Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title_fullStr | Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title_full_unstemmed | Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title_short | Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 |
title_sort | engineering exosomes and their application in cardiovascular field: bibliometric analysis from 2002 to 2022 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415707/ https://www.ncbi.nlm.nih.gov/pubmed/37576273 http://dx.doi.org/10.1016/j.heliyon.2023.e18809 |
work_keys_str_mv | AT zhangxiao engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT yangzijiang engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT jiangjizong engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT tangming engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT guanlongfei engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT leehangil engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT wanghongyun engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 AT xujiahong engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022 |